Journal Title：Neuromolecular Medicine

NeuroMolecular Medicine publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The information published in NEMM will provide a window into the future of molecular medicine for the nervous system.

《神經分子醫學》發表關于神經系統疾病的分子和生化基礎的前沿原創研究文章和評論。研究范圍從人類群體的遺傳分析到神經系統疾病的動物和細胞培養模型。將包括有關在分子和細胞水平上識別遺傳異常及其致病機制的新發現。還涵蓋了涉及神經系統發育和成人可塑性、神經功能障礙以及神經元退化和修復的分子級聯的實驗分析。《神經分子醫學》涵蓋分子遺傳學、信號轉導、可塑性和細胞死亡領域的基礎研究。NEMM 上發表的信息將為神經系統分子醫學的未來提供一個窗口。

Neuromolecular Medicine創刊于2002年，由Springer US出版商出版，收稿方向涵蓋醫學 - 神經科學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數3.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。